Mandate

Vinge has advised United Lithium Corp. in connection with the acquisition of Swedish Minerals AB

January 29, 2026 M&A

United Lithium is an exploration & development company focused on the global demand for lithium, uranium and rare earth elements.

The company is targeting lithium, uranium and rare earth element projects in politically safe jurisdictions with advanced infrastructure that allows for rapid and cost-effective exploration, development, and potential production opportunities.

Swedish Minerals’ uranium division controls one of the largest privately held uranium portfolios in the EU. The combination of the two companies positions them as a leading Nordicbased explorer supporting Europe’s accelerating clean energy transition and nuclear power resurgence.

Vinge’s team consisted of Christina Kokko, Alva Chambert, Emelie Herlitz, Ulrich Ziche, Daniel Wendelsson, Johan Cederblad and Stina Larsson.

Read United Lithium Corp’s press release here.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026